DGAP-News: Aladdin Healthcare Technologies SE / Key word(s): Miscellaneous
Aladdin Healthcare Technologies develops fully automated deep learning process to detect and distinguish COVID-19 from other diseases from CT images /research study published on IEEE Access
- Monitored deep learning process prevents false diagnoses
- Detection and classification of Covid-19 infections from CT images
- Requirements for manual marking of CT images minimized
- Broad application of the developed technology in large-scale clinical studies possible
- Study published in the journal of the Institute of Electrical and Electronics Engineers (IEEE)
BERLIN/LONDON, July 20, 2020 - Aladdin Healthcare Technologies SE ("Aladdin", ISIN: DE000A12ULL2), a leading developer of Artificial Intelligence (AI) based healthcare diagnostics and drug discovery applications, has successfully developed a fully automated deep learning process for the detection of COVID-19-infected regions in only four months, since March 2020. The technology can prevent false diagnoses of laboratory tests and, for example, distinguish pneumonia from COVID-19 cases.
The corresponding work by Aladdin Healthcare Technologies SE has been published in IEEE Access, a journal of the Institute of Electrical and Electronics Engineers: https://ieeexplore.ieee.org/document/9127422
COVID-19 disease can be fatal because the alveoli are severely damaged and progressive respiratory failure can occur. The risk of fatality in China is 4.03%. The highest rates so far have been found in Algeria (13.04%) and Italy (12.67%).
Wade Menpes-Smith, CEO of Aladdin Healthcare Technologies SE, comments: "Based on the promising results obtained qualitatively and quantitatively, we can envisage a wide deployment of our developed technique in large-scale clinical studies. This demonstrates the advanced capabilities of Aladdin to deliver best in class A.I. solutions even in emergency situations. The solution will be delivered to the Innovative Medicines Initiative (IMI) as part of the DRAGON project to combat COVID-19".
About Aladdin Healthcare Technologies SE
For further information:
Aladdin Healthcare Technologies Ltd.
20.07.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
Aladdin Healthcare Technologies SE
Unter den Linden 10
Regulated Market in Dusseldorf
EQS News ID:
End of News
DGAP News Service